secwatch / observer
8-K filed February 21, 2024, 6:59 PM ET ticker NGNE CIK 0001404644
leadership confidence high sentiment neutral materiality 0.15

Neurogene appoints Donna Cochener as SVP and General Counsel

Neurogene Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Donna Cochener

Senior Vice President, General Counsel
NGNE · Neurogene Inc.
Effective
2024-02-15
Filed
February 21, 2024, 6:59 PM ET
On February 15, 2024, Neurogene Inc. (the “Company”) appointed Donna Cochener as Senior Vice President, General Counsel.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Donna Cochener was appointed as Senior Vice President, General Counsel at Neurogene Inc..

Action
appointed
Role
Senior Vice President, General Counsel
Exact text from the filing
On February 15, 2024, Neurogene Inc. (the “Company”) appointed Donna Cochener as Senior Vice President, General Counsel.
View on SEC.gov

Neurogene Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-041440
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.